Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.5%

1 terminated/withdrawn out of 22 trials

Success Rate

95.5%

+8.9% vs industry average

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

71%

15 of 21 completed trials have results

Key Signals

15 with results

Enrollment Performance

Analytics

N/A
16(88.9%)
Phase 3
2(11.1%)
18Total
N/A(16)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT06602804Not ApplicableCompleted

Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study

Role: lead

NCT03737669Phase 3Completed

Mirasol Evaluation of Reduction in Infections Trial

Role: collaborator

NCT05239455Not ApplicableCompleted

An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System

Role: lead

NCT04358003Not ApplicableCompleted

Plasma Adsorption in Patients With Confirmed COVID-19

Role: collaborator

NCT01500681Completed

Maintenance Plasma Exchange for Neuromyelitis Optica

Role: collaborator

NCT02397278Not ApplicableCompleted

Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee

Role: collaborator

NCT03097289Not ApplicableCompleted

In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution

Role: lead

NCT02783313Not ApplicableCompleted

Pathogen Reduction Evaluation & Predictive Analytical Rating Score

Role: collaborator

NCT02302365Completed

Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion

Role: lead

NCT02754440Not ApplicableCompleted

Evaluation of Trima Version 7.0 Platelets in PAS

Role: lead

NCT02754492Not ApplicableCompleted

Evaluation of Trima Version 7.0 Platelets in 100% Plasma

Role: lead

NCT02298842Not ApplicableCompleted

In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution

Role: lead

NCT02684630Not ApplicableCompleted

Trima Accel® System Post Count Algorithm Study

Role: lead

NCT02308787Completed

Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions

Role: lead

NCT02253160Not ApplicableCompleted

An Evaluation of the Spectra Optia CMNC Collection Procedure

Role: lead

NCT01642563Phase 3Terminated

Italian Platelet Technology Assessment Study

Role: collaborator

NCT01901458Not ApplicableCompleted

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®

Role: collaborator

NCT01819246Not ApplicableCompleted

High Yield Intraoperative, Autologous Platelet Apheresis

Role: collaborator

NCT01805180Not ApplicableCompleted

Evaluation of the Spectra Optia PMN Cell Collection Procedure

Role: lead

NCT01736657Not ApplicableCompleted

Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients

Role: lead